Online citations, reference lists, and bibliographies.
← Back to Search

Serum Osteopontin Levels--is It Time To Screen Asbestos-exposed Workers For Pleural Mesothelioma?

M. Cullen
Published 2005 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
In this issue of the Journal, Pass et al.1 remind us yet again that the fallout from the once uncontrolled use of asbestos will remain with us for years to come. Thankfully, primary prevention of m...
This paper references



This paper is referenced by
ROLE D'ENDOCAN DANS LA CROISSANCE TUMORALE ET EFFETS DES ANTICORPS ANTI-ENDOCAN SUR LE DEVELOPPEMENT TUMORAL
B. Grigoriu (2006)
10.4081/MONALDI.2009.374
Clinical utility of diagnostic markers for malignant pleural mesothelioma.
B. Grigoriu (2009)
10.1164/rccm.1932p3
Work-related lung diseases.
A. Weston (2011)
10.1016/S1877-1203(09)72745-4
Maladies respiratoires professionnelles
M. Matrat (2004)
10.1158/1078-0432.CCR-06-2144
Utility of Osteopontin and Serum Mesothelin in Malignant Pleural Mesothelioma Diagnosis and Prognosis Assessment
B. Grigoriu (2007)
10.26616/nioshpub2011159
Asbestos fibers and other elongate mineral particles; state of the science and roadmap for research
Paul S. Schulte (2011)
10.1517/17530059.1.1.137
MESOMARK(®) in vitro diagnostic test for mesothelioma.
Zhong-Qian Li (2007)
10.1136/jclinpath-2012-201303
Challenges and controversies in the diagnosis of mesothelioma: Part 1. Cytology-only diagnosis, biopsies, immunohistochemistry, discrimination between mesothelioma and reactive mesothelial hyperplasia, and biomarkers
D. Henderson (2013)
10.1164/RCCM.200511-1789OC
Soluble mesothelin-related peptides in the diagnosis of malignant pleural mesothelioma.
A. Scherpereel (2006)
10.1016/J.EJCDT.2012.10.016
Combined blood and pleural levels of mesothelin and osteopontin for the diagnosis of malignant pleural mesothelioma
Wafaa M. Ashour (2012)
10.1309/BME4VG11LDX8KMTN
Immunohistochemical expression of osteopontin in epithelioid mesotheliomas and reactive mesothelial proliferations.
Dean-Yar Tigrani (2007)
10.1183/09031936.00226111
Effectiveness of mesothelin family proteins and osteopontin for malignant mesothelioma
I. Pantazopoulos (2012)
10.1007/978-0-387-72114-9_12
Neoplasms of the Pleura
S. Hammar (2008)
10.1309/h052-6244-4236-6v7u
Immunohistochemical Expression of Osteopontin in Epithelioid Mesotheliomas and Reactive Mesothelial Proliferations
Dean-Yar Tigrani (2007)
10.4314/TJPR.V9I6.63599
Malignant Pleural Mesothelioma Prognostic Marker: A Review of Osteopontin and Soluble Mesothelin Peptides
Franca Nneka Alaribe (2011)
10.1007/s00580-013-1720-x
RETRACTED ARTICLE: Combined blood and pleural levels of mesothelin and osteopontin for the diagnosis of malignant pleural mesothelioma
M. Fathy (2013)
10.1016/S0761-8425(06)71781-8
1. Comment évaluer une exposition à l’amiante et identifier une population à risque?
J. Pairon (2006)
10.3390/cancers2020523
Biomarkers for Early Detection of Malignant Mesothelioma: Diagnostic and Therapeutic Application
M. Tomasetti (2010)
10.3109/15563650.2010.506876
Occupational toxicology of asbestos-related malignancies
M. Lotti (2010)
Semantic Scholar Logo Some data provided by SemanticScholar